Jahchan, Nadine S <br/><br/>
A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors.  [electronic resource] 

 -  Cancer discovery  Dec 2013 
 - 1364-77 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>2159-8290 
<br/><br/><label>Standard No.: </label>10.1158/2159-8290.CD-13-0183  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antidepressive Agents, Tricyclic--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Computational Biology<br/>Drug Repositioning<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Mice<br/>Neuroendocrine Tumors--drug therapy<br/>Receptors, G-Protein-Coupled--antagonists & inhibitors<br/>Small Cell Lung Carcinoma--drug therapy<br/>Xenograft Model Antitumor Assays